2/20
12:31 pm
ardx
Ardelyx's post-earnings decline attributed to concerns over Ibsrela outlook [Seeking Alpha]
Low
Report
Ardelyx's post-earnings decline attributed to concerns over Ibsrela outlook [Seeking Alpha]
2/20
11:17 am
ardx
Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability [Seeking Alpha]
Medium
Report
Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability [Seeking Alpha]
2/20
08:03 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
Medium
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
2/20
07:04 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
2/20
12:16 am
ardx
Ardelyx Inc (ARDX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Developments ... [Yahoo! Finance]
Medium
Report
Ardelyx Inc (ARDX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Developments ... [Yahoo! Finance]
2/19
08:40 pm
ardx
Ardelyx Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Ardelyx Q4 Earnings Call Highlights [Yahoo! Finance]
2/19
04:27 pm
ardx
Ardelyx: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Ardelyx: Q4 Earnings Snapshot [Yahoo! Finance]
2/19
04:01 pm
ardx
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
High
Report
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/11
03:28 pm
ardx
Ardelyx, Inc. (ARDX) Reports Strong 2025 Revenue Growth, Updates 2026 Outlook [Yahoo! Finance]
Low
Report
Ardelyx, Inc. (ARDX) Reports Strong 2025 Revenue Growth, Updates 2026 Outlook [Yahoo! Finance]
2/5
09:27 am
ardx
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 [Yahoo! Finance]
Medium
Report
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 [Yahoo! Finance]
2/5
08:00 am
ardx
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
Medium
Report
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
2/3
09:12 am
ardx
Ardelyx Receives New Patent for Tenapanor [Yahoo! Finance]
Low
Report
Ardelyx Receives New Patent for Tenapanor [Yahoo! Finance]
2/3
08:29 am
ardx
Ardelyx Receives New Patent for Tenapanor
Low
Report
Ardelyx Receives New Patent for Tenapanor
2/2
09:44 am
ardx
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]
Low
Report
Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results [Yahoo! Finance]
1/29
10:59 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at TD Cowen.
1/29
08:03 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $17.00 price target on the stock.
1/28
07:02 pm
ardx
Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance [Yahoo! Finance]
Low
Report
Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance [Yahoo! Finance]
1/28
12:37 pm
ardx
How Ardelyx's Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors [Yahoo! Finance]
Low
Report
How Ardelyx's Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors [Yahoo! Finance]
1/28
08:29 am
ardx
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
Low
Report
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
1/27
07:19 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
1/26
10:16 am
ardx
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Low
Report
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
1/23
05:06 am
ardx
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/21
01:05 pm
ardx
Ardelyx: Assessment Of Acquisition Rumors [Seeking Alpha]
Low
Report
Ardelyx: Assessment Of Acquisition Rumors [Seeking Alpha]
1/21
09:05 am
ardx
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Wedbush from $16.00 to $19.00. They now have an "outperform" rating on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Wedbush from $16.00 to $19.00. They now have an "outperform" rating on the stock.
1/20
10:32 am
ardx
Ardelyx gains on report Zydus Lifesciences in talks to purchase [Seeking Alpha]
Low
Report
Ardelyx gains on report Zydus Lifesciences in talks to purchase [Seeking Alpha]